Legal Madness: COVID Call For Entries

Lawyers, I see you. I know what you’re doing in this pandemic. You are viewed as a place of intelligence, information, and direction. Your colleagues and clients likely turn to you for guidance as our world spins in uncertainty.

That means that you have stories.  Confidential, attorney-client privileged, awesome, virus-themed stories.

Legal Madness is collecting submissions (of all kinds) during the month of May.

What is Legal Madness? Last year, NYU Law School’s Engelberg Center and I gathered anonymous stories of in-house counsel, turned the tales into scripts, and hired actors to perform the monologues on stage. The first Legal Madness was a sold-out theatrical event that took place in New York City.

Even while being socially isolated, we are scaling the production.

Please submit your two-sentence, two-paragraph, or two-page real-life scenario via our private submission form on www.legalmadness.party.  Don’t pressure yourself … just click and send. Typos are my favorites. And we are not looking for law review or Great American Novel-quality writing. We are looking for truth, levity, weirdness, and heart. We all need that more than ever.

Thanks for all you do, lawyers, and nonlawyers. Keep safe, keep healthy, and keep hope. The theaters will reopen and we will laugh together.


Sarah was the General Counsel / first Lawyer at Etsy and Vroom.  She’s a co-founder of The Fourth Floor, a creator and producer of Legal Madness, an NYU Law School Engelberg Center fellow, a board member, an investor, and a speaker. You can also find Sarah hammering silver, eating candy, and chasing her child. sarahfeingold.com.

Tracking COVID-19’s Employment Law Impact: The Sheltering-In-Place Factor

What are the immediately apparent effects of the widespread state and local shelter-in-place orders on employment law?

For starters, more than 30 million jobless workers applied for unemployment since mid-March, according to those who keep track of the numbers. Across the states, there have been many reported delays in processing and disbursements of claims. That means that millions of workers are left without the income they need to pay for necessities, such as food, rent or mortgage payments, and utilities, let alone discretionary spending of any sort. 

Displaced workers. It also means that displaced workers are scrambling to find new sources of income, which often means employment as gig workers in the pandemic-prompted burgeoning home delivery service sector — groceries and restaurant-prepared meals, especially. 

Or they may be at home, currently receiving unemployment — including the $600 per week additional payment guaranteed by the CARES Act and that some fear will make cautious (or complacent) workers reluctant to return to the workplace, even as loosening restrictions in some states allow select businesses to reopen. Of course, most reopening states have made it fairly clear that if businesses are permitted and choose to reopen, their employees, absent specific circumstances, would no longer be unable to work and thus no longer eligible for unemployment. 

Payroll relief. Businesses that lacked financial means to keep employees on the payroll, even at reduced wages, until federal (or in some cases local) payroll relief became available, have faced a tough choice between closing down permanently or hanging on, with the hope of reopening when state and local governments start scaling back shelter-in-place directives. So much has depended on the financial relief available (and deliverable) to cover fixed costs like rent and utilities, even where all staffing has been furloughed or laid off. 

For example, clients are reportedly anxious about their Paycheck Protection Program CARES Act loans — if they were able to obtain them — since not more than 25% of the loan forgiveness amount may be attributable to non-payroll costs. That means these businesses must spend 75% of the loan proceeds on payroll. For business (like restaurants, for example), that can open at only 25% capacity, will they be able to spend 75% of the proceeds on payroll? 

Essential and white-collar workers. In the meantime, first responders, healthcare employees, and other essential workers have continued to work during the pandemic, with employers and employees alike struggling with how to keep working while implementing and managing safety protocols in the face of widespread shortages of personal protective equipment. And then there are workers in often higher-paid white collar jobs, many of which continued to be filled with work-from-home staff, 56% of whom like working from home (compared to 25% who don’t), according to a recent survey, and 68% of whom say they are equally or more productive at home than in their normal workplace. How amenable will they be to full-time work in a workspace that is likely to be markedly different than the one they left, due to a continued need for social distancing?

Greater demand. Taken together, this means that employment law practitioners are in still greater demand as businesses seek advice on closure, furlough, and layoff issues, unemployment compensation and federal loan programs, as well as such return-to-work issues as worker and customer safety compliance for those that remain open or contemplate reopening. 

Enticing those work-from-home workers back into a shared working environment in the face of uncertainties is another potential employment law issue. Employee leave and discharge issues also come into play, especially where workers have contracted COVID-19 infections, display symptoms, have been exposed to coworkers or others who have contracted the coronavirus, or must stay home to care for a child whose school has been forced to close — by mid-March, that was 46 states — and across the country, schools in 47 states have recommended that schools remain closed for the rest of the school year.  

And in every case, there is the fear of the virus — and the fear of liability.

Have the shelter-in-place orders changed employment law client demand for legal services, and if so, how?

Issues flowing from stay-at-home orders have created an uptick in the need for legal support on compliance issues that run the gambit from state and federal WARN Act obligations when businesses close, to state and federal OSHA requirements around worker safety, CDC guidance on the virus itself, and state and federal paid and unpaid leave requirements for businesses that have remained open or are contemplating what to do when they do reopen.   

Compliance with COVID-19 laws. Getting up to speed on the Families First Coronavirus Response Act (FFCRA) and Coronavirus Aid, Relief, and Economic Security (CARES) Act — legislation that moved through Congress very quickly in response to the pandemic — is a critical client concern. Federal guidance on employer obligations and employee protections has been updated a number of times in short order, and the application of this guidance to some circumstances remains unclear — at best. Yet the pace of implementation isn’t gradual: The paid sick time and paid and unpaid family and medical leave provisions of the FFCRA have already prompted federal agency action where employers have denied mandated leave. 

Re-opening compliance. Another area of intense interest for employers is the question of what procedures must be followed as businesses begin to reopen or move toward pre-pandemic functioning. Many of the requirements that apply are very nuanced by locality. One of the resources on Wolters Kluwer’s free Coronavirus Resources & Tools (COVID-19) website is its COVID-19 Smart Charts. The Labor & Employment/HR & Benefits “Back to Work” topic, as just one example, contains summaries of state back-to-work requirements, with links to full text. This state-specific information provides details as defined by state governments regarding essential and non-essential businesses, retail, bars and restaurants, healthcare (for voluntary and elective procedures), and other reopening mandates. For example, employers need to know, in customer-facing workplaces, what occupancy level applies? What customer and employee protections are mandated? Are masks to be required? Are employers required to provide them? The list seems endless.  

“Guidelines for Opening Up America Again.” At the same time, federal agencies such as the CDC, OSHA, the DOL, and the EEOC have all issued guidance with varying degrees of specificity impacting return-to-work issues. Plus, the Trump Administration, back in April, provided very specific reopening guidance for not only states, but also recommended specific actions by employers at each of three reopening phases. Because this reopening guidance has taken a back seat to some of the more recent state guidance when they have announced their reopening plans (which are not exactly congruent with this guidance in all respects), it bears mentioning here.

Three-phase approach. The Opening Up America guidance outlines three reopening phases based on defined gating criteria. States or regions should see downward trajectories of both influenza-like illnesses (ILI) and COVID-like syndromic cases reported within a 14-day period. There should also be a downward trajectory of either documented cases or positive tests as a percent of total tests (with a flat or increasing volume of tests) within a 14-day period. Further, under the gating criteria, hospitals should be treating all patients without crisis care and have a robust testing program in place for at-risk healthcare workers, including emerging antibody testing. The three phases are:

One: For states and regions that meet the gating criteria;

Two: For states and regions with no evidence of a rebound and that satisfy the gating criteria a second time; and

Three: For states and regions with no evidence of a rebound and that satisfy the gating criteria a third time.

Employers at all phases. During all phases, the guidelines instruct employers to develop and implement appropriate policies, in accordance with federal, state, and local regulations and guidance, and informed by industry best practices, regarding:

  • Social distancing and protective equipment;
  • Temperature checks;
  • Testing, isolating, and contact tracing;
  • Sanitation;
  • Use and disinfection of common and high-traffic areas; and
  • Business travel.

Employers should also monitor their workforce for indicative symptoms and should not permit symptomatic people to physically return to work until cleared by a medical provider. Further, employers should develop and implement policies and procedures for workforce contact tracing following an employee COVID+ test.

Employers at Phase One. Under the guidelines, at Phase One, all employers should:

  • Continue to encourage telework, whenever possible and feasible with business operations;
  • If possible, return to work in phases;
  • Close common areas where personnel are likely to congregate and interact, or enforce moderate social distancing protocols;
  • Minimize non-essential travel and adhere to CDC guidelines regarding isolation following travel; and
  • Strongly consider special accommodations for personnel who are members of a vulnerable population.

Vulnerable individuals include the elderly and people with serious underlying health conditions, including high blood pressure, chronic lung disease, diabetes, obesity, asthma, and those whose immune system is compromised such as by chemotherapy for cancer and other conditions requiring such therapy.

The guidelines also include industry-specific instructions at all phases for certain types of employers, such as schools, senior care facilities and hospitals, large venues, gyms, and bars. 

Employers at Phase Two. At Phase Two, all employers should:

  • Continue to encourage telework, whenever possible and feasible with business operations;
  • Close common areas where personnel are likely to congregate and interact, or enforce moderate social distancing protocols;
  • Non-essential travel can resume; and
  • Strongly consider special accommodations for personnel who are members of a vulnerable population.

Employers at Phase Three. At Phase Three all employers can resume unrestricted staffing at worksites. As to special employers:

  • Visits to senior care facilities and hospitals can resume, but those who interact with residents and patients must be diligent regarding hygiene;
  • Large venues (e.g., sit-down dining, movie theaters, sporting venues, places of worship) can operate under limited physical distancing protocols;
  • Gyms can remain open if they adhere to standard sanitation protocols; and
  • Bars may operate with increased standing room occupancy, where applicable.

Employers’ good faith compliance with governmental guidance (and that apparently means federal, state, and local — even when conflicting, as seems to be the case) should go a long way to providing them with some protection against potential litigation.

What are some of the additional obligations that employers have around employee leave and return to work issues?

The COVID-19 public health crisis has ushered in new federal paid and unpaid leave obligations as well as a patchwork of state and local ones. For employers doing business in multiple states, compliance can be confusing and complicated. And, the provisions of the FFCRA are not always clear as to certain nuances that can arise in the compliance environment.

Families First Act. The FFCRA, which went into effect on April 1, applies to private employers with fewer than 500 employees, with potential exemptions available for certain health care providers and first responders, and businesses with fewer than 50 employees when the imposition of requirements would jeopardize the viability of the business as a going concern. Two parts of the FFCRA are directed to employer leave obligations: the Emergency Paid Sick Leave Act (EPSLA) and the Emergency Family and Medical Leave Expansion Act (EFMLEA). 

Exemption confusion. For example, the FFCRA exempts who was narrowly defined in the FMLA to be a “health care provider” from the paid leave provisions due to the nature of the current crisis. But the DOL guidance redefines a “health care provider” to include “nearly any employee who happens to work for an employer who also employs a health care provider, works at any type of quasi-medical facility, works as an employee contracted for non-healthcare services in a facility that houses a health care provider, or merely works in the medical supply chain,” according to Democratic members of Congress who took issue with the DOL’s Q&As as to this exemption.  

Paid emergency sick leave. Generally, the FFCRA requires covered employers to provide eligible employees up to two weeks (80 hours) of paid sick leave at full pay (up to a specified cap) when the employee is unable to work due to a quarantine or isolation order related to COVID-19; has been advised by a health care provider to self-quarantine due to concerns related to COVID-19; or is experiencing COVID-19 symptoms and seeking a medical diagnosis.

The FFCRA also provides up to two weeks (80 hours) of paid sick leave at two-thirds pay (up to a specified cap) when an employee is unable to work because of a need to care for an individual who is under quarantine or isolation order or health care provider self-quarantine instructions due to COVID-19 concerns; a need to care for a son or daughter whose school or place of care is closed, or whose child care provider is unavailable, due to COVID-19; or is experiencing a substantially similar condition, as specified by the HHS Secretary (we don’t really know what this might be — the Secretary hasn’t yet specified).

Expanded FMLA leave. The FFCRA also requires covered employers to provide up to 12 weeks of expanded family and medical leave, up to 10 weeks of which must be paid at two-thirds pay (up to a specified cap) when an eligible employee is unable to work because the employee needs to care for a son or daughter whose school or place of care is closed, or whose child care provider is unavailable, for COVID-19 reasons. Here, employers may designate the first 10 days of the leave as unpaid.

Coordination of sick leave, expanded family leave, PTO? Note there is some overlap between the conditions under which employees may be entitled to take either paid sick leave or expanded family medical leave. And a well-known employment law blogger (Jon Hyman of Ohio Employers Blog fame) has characterized as “confounding” DOL rules under which employers can require employees to substitute an employer’s own provided leave (think PTO) for paid leave — the 80 hours of paid sick leave or the 12 weeks of expanded family and medical leave — mandated by the FFCRA.

Ogletree Deakins explains (in its FFCRA FAQs) that the first two weeks (usually 10 days) of expanded family medical leave are unpaid, but notes that the FFCRA also includes EPSLA paid sick leave (for school and childcare closures) that covers the same event, which would cover the first two weeks (unless the employee’s paid leave has been exhausted for other reasons). Notably, the EPSLA provides for paid sick leave in a much wider array of scenarios related to COVID-19 than the expanded family medical leave provisions do, so paid sick leave could be exhausted before an employee seeks expanded family medical leave. And then, the employee has the ability to substitute any other form of available paid leave he or she may have during those first 10 days.

Job restoration exemptions. Under the expanded FMLA provisions, normal reinstatement rules apply to most employers. However, employers with fewer than 25 employees are relieved of usual job restoration requirements when an employee who has been on leave returns to work and certain conditions are met: when the job that the employee previously had no longer exits due to economic conditions or other changes in operating conditions that affect employment and are caused by the pandemic during the leave period. The employer still has an obligation (1) to make reasonable efforts to restore the employee to an equivalent position, and (2) for one year, beginning on the earlier of the date of the qualifying need or 12 weeks after the leave began, to contact the employee if an equivalent position becomes available.

Check state and local leave laws. Employers should remember that pandemic-related leave obligations don’t end here, with federal law or federal regs. There are also state and local paid and unpaid sick or family and medical leave provisions that may apply to “fill the gap” that exists under the FFCRA, so that sick time and family and medical leave provisions apply to a broader range of employees. For example:

  • The governor of California has issued an executive order that gives food-sector workers up to 80 hours of COVID-19 supplemental paid sick leave when certain criteria are met.
  • In Colorado, the Department of Labor and Employment has implemented emergency rules that temporarily require employers in certain industries to provide up to four days’ paid leave to employees with flu-like symptoms who are awaiting COVID-19 testing. 
  • In San Francisco, new guidance provides that employees may use accrued paid sick time to quarantine, self-isolate, because they are among a “vulnerable population,” due to temporary business closures, or to care for family members or children.

Workplace safety. On top of that, when employees return to work, whether because a closed business has reopened or at an up-and-running business where employees who were on leave are returning to work, there are myriad safety issues that employers must consider. These, too, include directives issued by federal, state, and local authorities — and unfortunately for employers, the recommendations may be inconsistent or even conflicting.

On the federal scene, there has been a significant amount of OSHA guidance targeted to particular types of employers and employees. While this guidance does not carry the force of law or formal regulations, except perhaps as to respirator standards, employers should be aware that Secretary of Labor Eugene Scalia has made clear that this guidance is enforceable under the general duty clause of the Occupational Safety and Health Act.

Again, employers must also check state and local requirements. For example, in Delaware, an executive order mandates that employers require employees to wear a face covering while working in areas open to the public and in areas where coming within six feet of other staff is likely; provide at the business’ expense, face coverings and hand sanitizer for employees; and deny entry to individuals without a face covering — or if one is not available for them.

Ohio, too has issued mask requirements for employers and employees. The requirement to wear cloth face coverings applies to employers and employees at Ohio workplaces as they reopen, but there are exceptions. Employers and employees are not required to wear face coverings if it is not advised due to health reasons, against documented industry best practices, prohibited for a specific position by law or regulation, or a violation of a company’s safety policy. A face covering also is not required if an employee is working alone in an enclosed workspace or if there is a practical reason one cannot be worn. If any of these exceptions apply, written justification must be provided upon request.

Disability accommodations. As if these multiple reopening requirements are not enough to manage, employers also need to make sure they are accommodating COVID-19-related needs of employees with disabilities. Again, these legal obligations may exist not just under federal laws, but also on the state and local level as well. 

EEOC guidance. The EEOC has posted a series of questions and answers that address compliance issues under federal disability (and other antidiscrimination laws) that are very helpful for employers. 

On May 5, the EEOC added a three more questions and answers—and then quickly took one of them down. One of the questions addresses how an employee must request reasonable accommodation from her employer because she has one of the medical conditions that the CDC says may put her at higher risk for severe illness from COVID-19.”  Those medical conditions include chronic lung diseases, serious heart conditions, severe obesity, diabetes, liver disease, chronic kidney disease undergoing dialysis, and those who are immunocompromised. 

Individuals (the employee or someone on her behalf) may request accommodation verbally or in writing. While the employee (or third party) does not need to use the term “reasonable accommodation” or reference the ADA, they may. The employee or her representative should communicate that she has “a medical condition that necessitates a change to meet a medical need.” (This seems to be a deliberate choice to not use the words “disability requiring accommodation.”) After receiving a request, the employer may ask questions or seek medical documentation to help decide if the individual has a disability and if there is a reasonable accommodation, barring undue hardship, that can be provided. 

The question taken down addressed accommodation of employees with underlying medical conditions, which the agency believed had been “misinterpreted in press reports and social media.”

The agency’s third new question provided examples of what kinds of accommodations might eliminate, or reduce to an acceptable level, a “direct threat to self.” Some of the suggestions listed included:

  • Additional or enhanced protective gowns, masks, gloves, or other gear beyond what the employer may generally provide to employees.  
  • Additional or enhanced protective measures, for example, erecting a barrier that provides separation between an employee with a disability and coworkers/the public or increasing the space between an employee with a disability and others.  
  • Elimination or substitution of particular “marginal” functions.  
  • Temporary modification of work schedules (if that decreases contact with coworkers and/or the public when on duty or commuting) 
  • Moving the location of where one performs work (for example, moving a person to the end of a production line rather than in the middle of it if that provides more social distancing).  

State return to work accommodations. As an example of state protections that may apply, the Massachusetts attorney general has issued guidance under which essential workplaces remaining open during the pandemic should make accommodations for employees with disabilities that put them at greater risk of coronavirus infection, including allowing them to work from home, if possible, or transferring them to another shift or role that minimizes their interactions with the public.

Are there any lessons that employers should keep in mind that apply to leave and return-to-work issues during the pandemic?

Yes, far too many to count. 

So many resources. First, the number of freely available resources provided by employment lawyers to the general public (not just their paying clients) deserves mention — and may mean that employers are without excuse. Firms both large and small have dedicated significant time and effort to educating the public on the employment law ramifications of COVID-19. 

Just a few examples — out of hundreds (check out the Stanford Law School COVID-19 Memo Database, which contains dozens of firms and over 5,000 memos in the last two months) — are Dickinson Wright’s “COVID-19 Return-to-Work Checklist from an Employment Law Perspective,” FisherPhillips’ “Comprehensive And Updated FAQs For Employers On The COVID-19 Coronavirus,” Ogletree Deakins’ COVID-19 Resource Center “Return to Work”,  and Squire Patton Boggs’ “Employer’s Guide to Return-to-Work Issues: COVID-19 Public Health Emergency.” Jackson Lewis has a COVID-19 Daily Briefing covering a multitude of topics. 

Agency enforcement. Although it’s still early, the U.S. Department of Labor’s Wage and Hour Division already has taken compliance enforcement action where employers have refused to pay employees for FFCRA-qualified leave for health care provider directed self-quarantine with potential coronavirus symptoms, or to await a family member’s COVID-19 test. Employers should keep in mind that the Labor Department is on the beat in terms of enforcing FFCRA employer obligations and employee protections.

Litigation. And of course, the lawsuits are beginning to pile up. For example, we have already seen suits alleging that employers have failed to protect workers against workplace coronavirus transmission leading to death (Estate of Evans v. Walmart, Inc., and J2M-Evergreen, LLC); refused to implement adequate COVID-19 safety measures and instead incentivized sick workers to stay on the job (Rural Community Workers Alliance v. Smithfield Foods, Inc., and Smithfield Fresh Meats Corp., dismissed May 5); denied leave and fired an employee for requesting it to care for a child whose school closed for COVID-19 reasons (Jones v. Eastern Airlines, LLC); and fired an employee for refusing to violate a local shelter-in-place order to go to the workplace instead of permitting her to telework (Reggio v. Tekin & Associates, LLC). 

There is also a lawsuit against an employer not covered by the FFCRA, for allegedly failing to grant leave for self-isolation directed by a health care provider that was purportedly available under company’s own policy, which it represented as consistent with FFCRA protections (Robtoy v. The Kroger Company, dba Peyton’s Northern Distribution Center). 

Regardless of whether the plaintiffs in these cases get beyond the motion-to-dismiss and summary-judgment stages, they are a reminder to employers that it’s important to understand their legal obligations amid the COVID-19 crisis. Even where federal, state, or local government action is unlikely because guidance does not carry the force and effect of laws and regulations, there is always the possibility that adversely impacted workers will file a lawsuit — and where many employees are similarly affected, the possibility of a class action exists.

Traditional models of legal services delivery have been facing disruption in recent years — do you see the COVID-19 pandemic impacting trends in legal services?

Given the pandemic crisis, state and local shelter-in-place orders, and the reluctance of clients and practitioners alike to meet person-to-person unless absolutely necessary, legal services delivery has shifted toward attorney telework and client consultations through telephone- and video-conferencing. 

Virtual delivery. With the sharply declining economy, many law firms have had to furlough or lay off attorneys and staff in order to cope with the loss of business in the face of certain fixed expenses that continue. Cloud-based (distributed) law firms, like FisherBroyles, though, have the advantage of not having to worry about much of the fixed overhead associated with brick-and mortar law firms. This type of virtual legal services delivery will likely increase, especially as lawyers working at office-based law firms adjust more and more to the conveniences that teleworking offers.

Remote options to become the norm? According to a Dorsey & Whitney webinar on May 1, “Litigation: The Pandemic’s Next Wave,” “how we practice and how clients are impacted has changed forever.” Practitioners are reporting that depositions, mediation, and arbitration all seem to be lending themselves quite well to being conducted by telephone or computer video, with court reporters adjusting very well. For example, some believe that we won’t be going back to in-person depositions; perhaps for key witnesses only, but clients simply won’t pay for the time and travel that has been devoted to taking depos (or conducting depo prep) in person. 

Mediation also seems well suited to be conducted remotely rather than in person, especially in a process where the parties themselves rarely meet face-to-face anyway. Practitioners report remote mediation has been more successful than they expected, and without location restraints, parties have more ability to use their mediator of choice.

Arbitration too will be conducted remotely, perhaps adopting new technology and new procedures well before the judiciary does. Regardless, the pandemic will push the practice of law in ways we may not yet imagine.

What about the courts? As for the court system itself, there doesn’t seem to be a uniform response. And there are no clear indications when things will return to normal, although the situation changes rapidly. The Administrative Office of the U.S. Courts (AO) has handed out guidelines for restoring operations among the federal courts. The guidelines rely heavily on conditions in local communities and on objective data from local and state public health officials and the CDC, according to the AO. The Federal Judiciary COVID-19 Recovery Guidelines emphasize local decision-making by the courts as each considers multiple factors while moving through four phases, the final of which is a return to normal operations.

Will oral argument at the appellate level return to in-person or will there be some arguments conducted remotely? With the U.S. Supreme Court hearing oral arguments remotely for the first two weeks in May — and for the first time in history, making the audio available, live, to the public — does this portend any lasting change at the highest level? And how will that filter down into other appellate-level courts?

Do you foresee lasting changes to employment law that will endure past the point when the crisis has subsided?

On the other side of the coronavirus pandemic — whenever that will be — or perhaps as it continues to impact workplaces, we may see more robust and/or meaningful state and local laws and regulations around employer leave and health and safety obligations, should federal efforts be perceived as falling short. Depending on the outcome of the federal election in November, we may similarly see federal legislation and regulations that either bolter existing protections or create new ones.

Liability. On the liability front, we may see new theories of liability applying existing federal, state, and local law to perceived employer obligations rooted in pandemic-related conduct or failure to act that has arguably harmed workers, including class actions where groups of similarly situated workers have suffered similar harms.

In the meantime, there are some reports of an emerging “COVID-19 discount,” where plaintiffs’ attorneys may be willing to settle for less because of the uncertainties resulting from the virus. 

Expanded protections. But as a result of the gaps in protection that have surfaced during the COVID-19 pandemic, we may also see expanded protections for workers who have in the past not clearly fit into the description of “employees” protected under existing federal, state, and local laws and regulations — particularly for gig workers, temporary workers, and independent contractors. 

As the pandemic crisis continues and the pressure to provide additional or post-pandemic relief at the federal level mounts, and again, perhaps dependent on the November elections, we may also see negotiated legislative packages that include expanded worker protections in the collective bargaining and wage-hour realms.

How do you think employment practitioners will seek to differentiate themselves in the new competitive landscape?

As noted earlier, one thing many firms have done is to offer significant guidance digitally to the public generally, hoping to extend their reach beyond existing clients and perhaps generate significant goodwill at a time of national crisis. Will it be difficult to pull back from offering so much legal expertise for no cost? Will law firms experience a devaluing of their expertise resulting from the sheer amount of available information?  

Regardless, growing out of the shelter-in-place orders we expect that practitioners will offer greater availability to clients through teleconferencing, Skype, and video options that save client costs, including for travel, as well as save attorney time. The prevalence of work-from-home may also see attorneys expand the hours they make legal services available to clients beyond the traditional 9-5. 

Practitioners also will likely increase their profiles through social media, online information, client alerts, Facebook chats, webinars, and other digital options. And, of course, the pandemic is likely to accelerate the transition to cloud-based models of legal practice so that firms may lower fixed expenses and provide legal services at lower cost to clients.


Joy P. Waltemath is Managing Editor for Labor & Employment Law Daily and compliance-related Bankruptcy, Energy, Insurance, Products Liability and Safety, and Transportation products for Wolters Kluwer Legal & Regulatory U.S. 

Pamela Wolf is a Senior Editor/Analyst for Employment Law Daily. She has been a member of the labor and employment team at Wolters Kluwer Legal & Regulatory U.S. for 15 years.

One Of World’s Top 10 Law Firms Is The Latest Victim Of COVID Cuts

(Image via Getty)

Don’t look now, but worries over the financial impact of the novel coronavirus have infiltrated yet another successful Biglaw firm. As we’ve noted time and again, no matter how impressive a firm’s gross revenue is, austerity measures may be coming down the pipeline thanks to the unrivaled havoc that COVID-19 has wreaked upon the world’s markets.

Today, we have news from Eversheds Sutherland, a firm that was declared the 10th best legal practice in the world in Law360’s most recent Global 20 rankings. It seems that the international firm’s U.S. branch is slashing salaries across the firm and furloughing employees. Specifically, the Eversheds equity partners will “lead the way” when it comes to reduced compensation, taking smaller distributions, and both lawyers and staff will face a 10 percent pay cut on average (including bonuses). Those who earn $50,000 or less will not have their compensation reduced. In addition, 40 staff members — about one-third of whom can’t do their work remotely — will be furloughed for three months’ time thanks to the pandemic.

On top of these COVID cuts, the firm plans to defer the start date for its incoming first-year associates to January 2021, and will be hosting a shortened summer associate program online. All law students who take part in the remote summer program will receive full-time job offers.

“[A]s we look at the economic news and listen to our clients, we are planning for future reductions in work. I think this is an appropriate, prudent preparation for the future, given everything we’re seeing,” Mark Wasserman, the firm’s U.S. co-chair, said in an interview. “We’re preparing for what we think will be less work for the short term. We don’t want to be caught off guard. We can always dial [these measures] back if there is a faster recovery.”

On the bright side, the firm has an employee relief fund that those facing unforeseen hardships — like furloughs — will be able to take advantage of these difficult times.

If your firm or organization is slashing salaries, closing its doors, or reducing the ranks of its lawyers or staff, whether through open layoffs, stealth layoffs, or voluntary buyouts, please don’t hesitate to let us know. Our vast network of tipsters is part of what makes Above the Law thrive. You can email us or text us (646-820-8477).

If you’d like to sign up for ATL’s Layoff Alerts, please scroll down and enter your email address in the box below this post. If you previously signed up for the layoff alerts, you don’t need to do anything. You’ll receive an email notification within minutes of each layoff, salary cut, or furlough announcement that we publish.


Staci ZaretskyStaci Zaretsky is a senior editor at Above the Law, where she’s worked since 2011. She’d love to hear from you, so please feel free to email her with any tips, questions, comments, or critiques. You can follow her on Twitter or connect with her on LinkedIn.

Are Lesser-Known Hemp-Derived Cannabinoids Legal?

The enactment of the 2018 Agricultural Improvement Act (the 2018 Farm Bill) and the legalization of hemp and hemp derivatives, including hemp-derived cannabidiol (CBD), has led to a massive CBD craze. Nevertheless, the FDA’s position against the sale and marketing of CBD-infused foods and dietary supplements has resulted in an insurgence of products infused with lesser-known cannabinoids.

In light of this recent shift in the industry, this piece explores how these “novel” cannabinoids might be regulated as foods or dietary supplements under federal law, using the current CBD regulatory framework as a starting point.

Before diving into the regulatory framework of these lesser-known cannabinoids, it is important to understand what cannabinoids are.

Cannabinoids are chemical compounds found in the cannabis plant. The most notable cannabinoids are tetrahydrocannabinol (THC), which is the most psychoactive compound in cannabis, and CBD, THC’s nonpsychoactive cousin. Yet, there are over 100 compounds in the cannabis plant that affect the human body in their own unique way. Two cannabinoids have begun getting a lot of attention are cannabigerol (CBG) and cannabinol (CBN).

CBG is the “mother” of all cannabinoids; it helps synthesize other cannabinoids, primarily THC and CBD. Though scientific research remains sparse, CBG has been found to act on specific physiological systems and problems, such as treating glaucoma, decreasing inflammation, and offering antibacterial properties.

While CBG is the precursor of cannabinoids, CBN is the product of a degradation of other cannabinoids. Specifically, CBN comes from the oxidation and decomposition of THC. As for CBG, current research on the effects of CBN is limited; yet, CBN is showing promise as a potent antibacterial agent, an appetite stimulant and as a possible sedative.

CBG and CBN, like CBD, fall under the federal definition of hemp, which means these cannabinoids can be lawfully cultivated so long as they contain no more than 0.3% THC on a dry-weight basis. Because CBG is formed prior to THC in the hemp plant, many in the industry believe cultivating CBG strains will help them circumvent the stringent preharvest “total THC” testing requirement imposed under the USDA’s Interim Rules. CBN strains, however, may not afford the same advantage, given most growers’ inability to cultivate CBN-rich strains. Nevertheless, technologies that convert CBD and THC into CBN are beginning to emerge. This technological change will create a new set of legal issues. For instance, some commentators believe that THC-derived CBN may be treated as an illegal substance under the Federal Analogue Act (FAA). The FAA provides that any substance “substantially similar” to a Schedule 1 controlled substance should also be treated as a Schedule 1 substance. However, this theory is purely speculative and remains to be tested in a court of law.

Similarly to CBD-infused foods and dietary supplements, CBG and CBN products fall under the jurisdiction of the FDA. This is because the 2018 Farm Bill expressly preserves the agency’s authority to regulate products containing cannabis or cannabis-derived compounds under the Food, Drug and Cosmetic Act (the FDCA) and Section 351 of the Public Health Service Act.

CBG and CBN, unlike CBD, have not been approved or investigated by the FDA as new drug ingredients, which means the Drug Exclusion Rule should not apply to these two lesser-known cannabinoids. Indeed, the Drug Exclusion Rule provides that any substance that has been approved or investigated by the FDA as a new drug cannot also be sold and marketed as a food or dietary supplement, unless the substance was sold and marketed as such before investigation. In the absence of the Drug Exclusion Rule, the question of whether CBG and CBN may be sold and marketed as a food or a dietary supplement depends on whether these cannabinoids are safe for human consumption.

Under the FDCA, any ingredient found in a food sold and marketed in interstate commerce is subject to FDA premarket approval, unless the substance is generally recognized as safe (GRAS). A substance is considered GRAS if it is proven to be safe among experts qualified by scientific training and experience to evaluate its safety under the conditions of its intended use.

Although the FDA has determined three hemp seed ingredients, namely hulled hemp seed, hemp seed protein powder, and hemp seed oil, to be GRAS, the agency has yet to make the same determination for CBD and other cannabinoids. This means that until the FDA explores the safety of these cannabinoids, any CBG- or CBN-infused food sold and marketed in interstate commerce will violate the FDCA.

Pursuant to Section 413 of the FDCA (21. U.S.C. 450b), any dietary supplement that contains a new ingredient — an ingredient not found in a dietary supplement sold and marketed before October 15, 1994 –- must notify the FDA about that ingredient prior to marketing, and provide the agency with information that is the basis on which the manufacturer or distributor has concluded that their product will reasonably be expected to be safe under the conditions recommended or suggested in the labeling. If the manufacturer or distributor receives a no-objection letter from the FDA, or no response at all, they may lawfully market their dietary supplement after the 75-day notification period is over, so long as their scientific evidence of safety is reliable.

Lastly, as for any CBD products, manufacturers and distributors of CBG and CBN-infused foods and dietary supplements should steer clear of any medical claims about the therapeutic values of their products. Doing so would suggest that the products’ intended use is that of a drug, and thus, would violate the FDCA and warrant FDA enforcement actions.

To conclude, given the limited amount of studies on the effects of CBG and CBN, the sale and marketing of these products remains risky under the FDCA. Nevertheless, as reliable scientific research continues to grow, it will give these two lesser-known cannabinoids a viable legal runway in the food and dietary supplement market.


Nathalie Bougenies practices in the Portland office of Harris Bricken and was named a “2019 Rising Star” by Super Lawyers Magazine, an honor bestowed on only 2.5% of eligible Oregon attorneys. Nathalie’s practice focuses on the regulatory framework of hemp-derived CBD (“hemp CBD”) products. She is an authority on FDA enforcement, Food, Drug & Cosmetic Act and other laws and regulations surrounding hemp and hemp CBD products. She also advises domestic and international clients on the sale, distribution, marketing, labeling, importation and exportation of these products. Nathalie frequently speaks on these issues and has made national media appearances, including on NPR’s Marketplace. Nathalie is also a regular contributor to her firm’s Canna Law Blog.

Here’s what hospitals got in the first round of CARES Act payments – MedCity News

Cash-crunched healthcare providers received their first emergency payments from the Department of Health and Human Services last month. So far, Congress has allocated a total of $175 billion in relief for healthcare providers to help them recoup losses tied to the Covid-19 pandemic.

HHS released new data sharing where those initial payments have gone. The first $50 billion in CARES Act funding was distributed to hospitals last month based on their patient revenue.

The first $30 billion of that went to hospitals based on their Medicare fee-for-service reimbursements, which HHS said would allow the funds to be distributed quickly, but put hospitals that see more Medicaid patients at a disadvantage. Another $20 million was distributed in late April based on providers’ share of net patient revenue.

Here’s which health systems saw the most of that funding:

  1. Dignity Health: $180,264,488
  2. Cleveland Clinic: $103,289,897
  3. Stanford Health Care: $102,405,229
  4. Memorial Hermann Health System: $92,422,556
  5. NYU Langone Hospitals: $92,120,455
  6. The County of Los Angeles: $80,867,712 (The County of Los Angeles operates four hospitals, including Harbor-UCLA Medical Center and LAC+USC Medical Center)
  7. Hackensack Meridian Health: $76,839,719
  8. Florida Cancer Specialists & Research Institute: $67,343,375
  9. Memorial Hospital for Cancer and Allied Diseases: $64,048,724
  10. Massachusetts General: $58,076,206

The hospitals listed above only include facilities that accepted HHS’ terms and conditions for receiving the funding as of May 4. As part of those terms, hospitals must agree not to “balance bill” Covid-19 patients, meaning they cannot charge an out-of-network patient more than they would pay if they had been in-network.

Separately, publicly-traded health systems have shared how much their facilities received in CARES Act payments. The largest for-profit hospital operator, HCA Healthcare, received $700 million in payments. Tenet received $345 million, Community Health Systems received $245 million and Universal Health Services received $195 million.

HHS also shared some additional information on how much states will receive in payments for hospitals in Covid-19 hotspots and rural hospitals. Here’s how those payments will be distributed:

Photo credit: Bill Oxford, Getty Images

New hope for a new Covid-19 vaccination that could be accessed by mail – The Zimbabwean

A British company, Stabilitech  Biopharma that owns the IP for thermally stable capsules for the administering of vaccines could be a front runner to be first past the post with a solution to the global pandemic with its Covid-19  vaccine which will offer double immunity and can be self- administered,  saving even the most vulnerable from a high-risk visit to a healthcare professional.

Human trials on Stabilitech’s  OraPro-COVID-19 vaccines are due to start next month and could be available by the end of the year. The company, that has already developed a successful Zika virus vaccine, is currently raising  R140m to complete human trials and begin manufacturing. This should get underway before the end of the year.

What sets this vaccine apart from other proposed vaccines currently under development is it comes in capsule form and can even be delivered to users in the mail.  They can also be widely and cost-effectively distributed, even in the hottest climates without need for refrigeration. A single dose of the orally administered vaccine will take up to three weeks to become effective while other Coronavirus vaccines in the pipeline may require more than one dose and take longer to provide immunity.

Wayne Channon, chairman of Stabilitech, says that delivering a COVID-19 vaccine in the shortest time possible is only half the challenge.  “Delivering a vaccine that works is more important.   COVID-19 infects the mucous membranes, or linings, of the ear, nose throat and lungs. That is why we are targeting our vaccine to hit COVID-19 where it sits – in mucosal cells. Other vaccines are currently only targeting the systemic immune system, but we know from our research that COVID -19 is a mucosal virus, therefore all vaccine developers should also be looking for a vaccine that targets both mucosal as well as systemic immunity. This is what OraPro- COVID-19 will  deliver in a single capsule.”

According to Channon,  because Stabilitech’s COVID-19 capsules contain a freeze-dried COVID-19 vaccine and are thermally stable, means they do not need refrigeration, as most other vaccines do.  It can be simply mailed and self-administered: “Even the most vulnerable and shielded can benefit without a high-risk visit to a healthcare professional. Once it has been delivered via post, you can simply swallow the capsule. No injections, no needles, no nurse or doctor’s visit, therefore no need for PPE that’s still in such short supply. And no expensive cold-chain storage is required like most other vaccines currently under development’, he said.

Stabilitech’s founder and Chief Scientific Officer Dr Jeff Drew – a virologist who has over 40 biotech patents to his name –  says: “To generate protective immunity, first we insert the Spike-protein DNA from COVID-19, the S-protein cargo, into a non-replicating adenovirus, the viral vector. OraPro’s thermal stability technology is applied and packaged within an acid-resistant capsule that protects the vaccine as it passes through the stomach before being dissolved in the gut. Because it is thermally stable, the vaccine is unharmed by the high – 37 degrees centigrade – temperatures in the stomach.

“The viral vector delivers the S-protein cargo DNA to mucosal intestinal cells, which produces copies of the COVID-19 S-protein. These cells deliver the S-protein to the cell membrane that results in mucosal and systemic immunity. It takes two to three weeks for the immunity to develop.”

Initial animal safety trials have been successfully concluded and the next stage of Stabilitech’s OraPro COVID-19 development is clinical trials, under the supervision of the regulator, the  UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

Trials are set to start in June, and a vaccine could be available by the end of the year. To achieve this, Stabilitech requires £6m (R150m) in funding for the clinical trials and manufacturing the capsule. Innovate UK, the government agency for funding research,  requested Stabilitech to repurpose its Zika funding to start the research and development of OraPro-COVID-19 but the greater investment is required to finance this next vital stage of development.

Post published in: Featured

Morning Docket: 05.08.20

* Legal Sea Foods has filed a lawsuit against their insurer over business interruption insurance. Bet they hope the denial of their claim was just a “fluke.” [Boston Herald]

* A judge has dismissed a lawsuit stemming from a sex tape involving Kevin Hart. Sounds like this could form the basis of another Jumanji sequel. [Atlanta Journal Constitution]

* The Department of Justice has dropped criminal charges against Michael Flynn. [AP]

* A federal appeals court has ruled on legal fees to be doled out in the NFL concussion litigation. Don’t remember lawyers being involved in the Will Smith movie… [Legal Intelligencer]

* Tara Reade, who accuses Joe Biden of sexual assault, has hired a lawyer who represented six Harvey Weinstein victims. [New York Magazine]

* Zoom will start cracking down on Zoombombing in a deal with the New York Attorney General. Will Ferrell should still be allowed to crash Zoom calls… [NPR]


Jordan Rothman is a partner of The Rothman Law Firm, a full-service New York and New Jersey law firm. He is also the founder of Student Debt Diaries, a website discussing how he paid off his student loans. You can reach Jordan through email at jordan@rothmanlawyer.com.

UAE Sends Medical Aid to Zimbabwe in Fight Against COVID-19 – The Zimbabwean

The aid will assist more than 7,700 medical professionals as they work to combat the virus.

Commenting on the aid delivery, His Excellency Dr. Jassim Mohammed Mubarak Al Qasimi, UAE Ambassador to Zimbabwe, stated: “The UAE is honored to play a part in the tireless efforts of countries working to contain COVID-19. This medical aid will assist healthcare professionals in Zimbabwe with their immediate needs, ensuring they may serve on the front lines while equipped with the necessary protection.”

“The UAE considers Zimbabwe a vital partner and is committed to assisting African countries in their fight against COVID-19,” His Excellency remarked.

To date, the UAE has provided more than 448 metric tons of aid to over 40 countries, supporting nearly 448,000 medical professionals in the process.

Post published in: Featured

Opposition party walks out of parliament – The Zimbabwean

8.5.2020 8:29

Disengaging from anything to do with parliament or ruling party, says opposition leader

HARARE, Zimbabwe – Zimbabwe’s main opposition bloc has suspended participation in all parliamentary proceedings after the expulsion of four legislators.

The decision was taken after a breakaway faction of the opposition Movement for Democratic Change Alliance (MDC Alliance) allegedly connived with the ruling Zimbabwe African National Union-Patriotic Front (Zanu-PF) for the dismissal of the four legislators.

The four expelled legislators are Charlton Hwende, Prosper Mutseyami, Thabitha Khumalo, and Senator Lilian Timveous.

On Thursday, Job Sikhala, acting national chairman of the MDC Alliance, announced the expulsion of three leaders – Morgen Komichi, Elias Mudzuri, and Douglas Mwonzora – who were linked to the breakaway faction.

“As the MDC Alliance, we are disengaging from anything to do with Parliament and from anything to do with Zanu-PF,” he said.

However, he said a final decision about the withdrawal will be taken after consultations with “the party’s structures and other interest groups.”

The MDC Alliance’s breakaway faction is led by one of its former vice presidents, Thokozani Khupe.

Meanwhile, the ruling Zanu-PF has refuted allegations that it had a hand in the expulsion of legislators belonging to the MDC Alliance.

On Wednesday, Tafadzwa Mugwadi, its information director, said the party was not bothered about the opposition bloc’s affairs.

“They are destroying themselves. It [MDC Alliance] is not quite here nor there, and is in no position to be pointing fingers at Zanu-PF,” said Mugwadi.

Post published in: Featured

Zimbabwe Situation Report, 7 May 2020 – The Zimbabwean

  • The first imported COVID-19 case was reported on 21 March 2020 and local transmission started on 24 March. As of 5 May, 34 COVID-19 cases were confirmed, including four deaths.
  • A malaria outbreak, with over 226 deaths reported since 1 January 2020 throughout the country, creates an additional burden to an already fragile health system.
  • Over 2 million people received food or cash assistance in April. Distributions were delayed due to the implementation of COVID-19 protection measures.
  • The number of children treated for acute malnutrition reduced from 1,989 in January to 1,852 in February and 1,708 in March in the entire country.
  • The national GBV Hotline recorded 1,273 GBV calls since the beginning of the lockdown on 30 March with an overall increase of over 100 per cent compared to pre-lockdown trends.

BACKGROUND

Situation Overview

The 2020 Zimbabwe Humanitarian Response Plan (HRP), launched on 2 April 2020, indicates that 7 million people in urban and rural areas are in urgent need of humanitarian assistance across Zimbabwe, compared to 5.5 million in August 2019. Since the launch of the Revised Humanitarian Appeal in August 2019, circumstances for millions of Zimbabweans have worsened. Drought and crop failure, exacerbated by macro-economic challenges and austerity measures, have directly affected vulnerable households in both rural and urban communities. Inflation continues to erode purchasing power and affordability of food and other essential goods is a daily challenge. The delivery of healthcare, clean water and sanitation, and education has been constrained and millions of people are facing challenges to access vital services.

There are more than 4.3 million people severely food insecure in rural areas in Zimbabwe, according to the latest Integrated Food Security Phase Classification (IPC) analysis, undertaken in February 2020. In addition, 2.2. million people in urban areas, are “cereal food insecure”, according to the most recent Zimbabwe Vulnerability Assessment Committee (ZimVAC) analysis. Erratic and late 2019/2020 rains forebode the possibility of a second poor harvest. Nutritional needs remain high with over 1.1 million children and women requiring nutrition assistance. At least 4 million vulnerable Zimbabweans are facing challenges accessing primary healthcare and drought conditions trigger several health risks. Decreasing availability of safe water, sanitation and hygiene have heightened the risk of communicable disease outbreaks for 3.7 million vulnerable people. Some 1.2 million school-age children are facing challenges accessing education. The drought and economic situation have heighted protection risks, particularly for women and children. A year after Cyclone Idai hit Zimbabwe, 128,270 people remain in need of humanitarian assistance across the 12 affected districts in Manicaland and Masvingo provinces. There are 21,328 refugees and asylum seekers in Zimbabwe who need international protection and multisectoral life-saving assistance to enable them to live in safety and dignity.

As of 5 May, the Ministry of Health and Child Care (MoHCC) in Zimbabwe had reported 34 confirmed COVID-19 cases including four deaths, with cases reported in five provinces including 13 cases in Harare and 12 cases in Bulawayo, and a total of 11,647 screenings and diagnostic tests done. With the first cases reported in Zimbabwe as of 21 March, and the recent increase of COVID-19 transmission in the region, the Government of Zimbabwe is strengthening and accelerating preparedness and response to the COVID-19 outbreak. Following the declaration of COVID-19 as a national disaster on 19 March 2020, the Zimbabwe National Preparedness and Response Plan for COVID-19 was launched with an initial eight pillars of coordination, the creation of a national COVID-19 Response Task Force and the formation of the Inter-Ministerial Committee. The Government of Zimbabwe declared a 21-day nationwide lockdown starting on 30 March 2020 ensuring the continuity of essential services. This was reviewed and extended by two weeks until 3 May. On 1 May, the Government announced the easing of lockdown regulations which allowed formal industry and commerce to resume operations, having met the specified regulations including mandatory testing and screening of employees. These measures will be in effect until 17 May.

The country is currently facing a malaria outbreak that is creating an additional burden to an already fragile health system. From 1 January to 26 April 2020, more than 236,365 malaria cases and 226 deaths have been reported. During the week from 20 to 26 April, a total of 33,171 malaria cases and 21 deaths were reported representing a 220 per cent increase in cases compared to similar period in 2019. The number of health facilities reporting malaria outbreaks remain on the rise, with highly affected provinces being Manicaland, Mashonaland East and Mashonaland Central.

In addition to the commitments to the HRP recorded above through the Financial Tracking System (FTS), a number of pledges are in the process of being realized. This includes $13 million from the European Commission for which a call for proposals has been launched, $44 million COVID-19 funding announced by the UK Ambassador, and a further $20 million CERF allocation to WFP for Social Protection programming. The Government of Japan also announced the commitment of $15.3 million in emergency funding including $14.8 million to WFP, $455,000 to UNICEF and $96,000 to IOM.

Post published in: Featured